Literature DB >> 1955820

Analysis of fixed-ratio behavior maintained by drug reinforcers.

P Skjoldager1, G Winger, J H Woods.   

Abstract

Behavior maintained by intravenously delivered alfentanil, cocaine, or ketamine was assessed using a fixed-ratio schedule of reinforcement. As the dose of each drug was increased, rate of responding also increased up to a maximum. Further increases in dose resulted in decreased response rates (inverted U-shaped curve). An analysis of postreinforcement-pause-time and run-time measures for the ascending limb of the inverted U-shaped functions revealed that behavior was characterized by systematic decreases in both pause time and run time as dose and rate increased. An examination of the descending limb of the dose-response functions revealed that lowered response rates for cocaine and ketamine were correlated with increases in run time and small and inconsistent effects on postreinforcement pause time. Behavior maintained by rate-reducing doses of alfentanil was characterized by lengthened postreinforcement pauses with small increases in run time. These data suggest that at larger doses, drug reinforcers may have unconditioned or direct effects on the behavior that the drug is maintaining, and more important, that the nature of these unconditioned effects depends on the drug that is maintaining behavior.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1955820      PMCID: PMC1323106          DOI: 10.1901/jeab.1991.56-331

Source DB:  PubMed          Journal:  J Exp Anal Behav        ISSN: 0022-5002            Impact factor:   2.468


  22 in total

1.  Effects of increment size and reinforcer volume on progressive ratio performance.

Authors:  W HODOS; G KALMAN
Journal:  J Exp Anal Behav       Date:  1963-07       Impact factor: 2.468

2.  Satiation effects under fixed-ratio schedules of reinforcement.

Authors:  M SIDMAN; W C STEBBINS
Journal:  J Comp Physiol Psychol       Date:  1954-04

3.  Codeine- and cocaine-reinforced responding in rhesus monkeys: effects of dose on response rates under a fixed-ratio schedule.

Authors:  D A Downs; J H Woods
Journal:  J Pharmacol Exp Ther       Date:  1974-10       Impact factor: 4.030

4.  Cocaine-reinforced behavior in rats: effects of reinforcement magnitude and fixed-ratio size.

Authors:  R Pickens; T Thompson
Journal:  J Pharmacol Exp Ther       Date:  1968-05       Impact factor: 4.030

5.  Self-administration of d-amphetamine by rats.

Authors:  R Pickens; W C Harris
Journal:  Psychopharmacologia       Date:  1968

6.  Molecular analyses of the effects of d-amphetamine on fixed-interval schedule performances of rats.

Authors:  F McAuley; J C Leslie
Journal:  J Exp Anal Behav       Date:  1986-03       Impact factor: 2.468

7.  Oral d-amphetamine and ketamine self-administration by rhesus monkeys: effects of food deprivation.

Authors:  M E Carroll; D C Stotz
Journal:  J Pharmacol Exp Ther       Date:  1983-10       Impact factor: 4.030

8.  Oral drug self-administration in rhesus monkeys: interactions between drug amount and fixed-ratio size.

Authors:  G A Lemaire; R A Meisch
Journal:  J Exp Anal Behav       Date:  1985-11       Impact factor: 2.468

9.  Pentobarbital self-administration in rhesus monkeys: drug concentration and fixed-ratio size interactions.

Authors:  G A Lemaire; R A Meisch
Journal:  J Exp Anal Behav       Date:  1984-07       Impact factor: 2.468

10.  Intravenous self-administration of dopamine receptor agonists by rhesus monkeys.

Authors:  W L Woolverton; L I Goldberg; J Z Ginos
Journal:  J Pharmacol Exp Ther       Date:  1984-09       Impact factor: 4.030

View more
  12 in total

1.  Similar consumption and responding across single and multiple sources of drug.

Authors:  W K Bickel; G J Madden
Journal:  J Exp Anal Behav       Date:  1999-11       Impact factor: 2.468

Review 2.  A review of human drug self-administration procedures.

Authors:  Jermaine D Jones; Sandra D Comer
Journal:  Behav Pharmacol       Date:  2013-09       Impact factor: 2.293

3.  Parametric analysis of cocaine self-administration under a progressive-ratio schedule in rhesus monkeys.

Authors:  J K Rowlett; B W Massey; M S Kleven; W L Woolverton
Journal:  Psychopharmacology (Berl)       Date:  1996-06       Impact factor: 4.530

4.  Matching under nonindependent variable-ratio schedules of drug reinforcement.

Authors:  R A Meisch; R Spiga
Journal:  J Exp Anal Behav       Date:  1998-07       Impact factor: 2.468

Review 5.  Environmental modulation of drug taking: Nonhuman primate models of cocaine abuse and PET neuroimaging.

Authors:  Michael A Nader; Matthew L Banks
Journal:  Neuropharmacology       Date:  2013-06-07       Impact factor: 5.250

6.  Influence of sex and estrous cyclicity on conditioned cue-induced reinstatement of cocaine-seeking behavior in rats.

Authors:  Rita A Fuchs; K Allison Evans; Ritu H Mehta; Jordan M Case; Ronald E See
Journal:  Psychopharmacology (Berl)       Date:  2005-01-29       Impact factor: 4.530

7.  Detailed analysis of food-reinforced operant lever pressing distinguishes effects of a cannabinoid CB1 inverse agonist and dopamine D1 and D2 antagonists.

Authors:  P J McLaughlin; K M Winston; L A Swezey; V K Vemuri; A Makriyannis; J D Salamone
Journal:  Pharmacol Biochem Behav       Date:  2010-04-18       Impact factor: 3.533

8.  Behavioral and neurochemical effects of amphetamine analogs that release monoamines in the squirrel monkey.

Authors:  Heather L Kimmel; Daniel F Manvich; Bruce E Blough; S Stevens Negus; Leonard L Howell
Journal:  Pharmacol Biochem Behav       Date:  2009-09-17       Impact factor: 3.533

9.  Ratio size and cocaine concentration effects on oral cocaine-reinforced behavior.

Authors:  M J Macenski; R A Meisch
Journal:  J Exp Anal Behav       Date:  1998-09       Impact factor: 2.468

10.  Patterns of responding differentiate intravenous nicotine self-administration from responding for a visual stimulus in C57BL/6J mice.

Authors:  Candice Contet; Kimberly N Whisler; Holly Jarrell; Paul J Kenny; Athina Markou
Journal:  Psychopharmacology (Berl)       Date:  2010-07-29       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.